Apixaban exhibits anti-arthritic effects by inhibiting activated factor X-mediated JAK2/STAT3 and MAPK phosphorylation pathways. [electronic resource]
Producer: 20210701Description: 1253-1267 p. digitalISSN:- 1568-5608
- Animals
- Antioxidants -- pharmacology
- Antirheumatic Agents -- pharmacology
- Arthritis, Experimental -- drug therapy
- Arthritis, Rheumatoid -- drug therapy
- Disease Progression
- Factor Xa -- drug effects
- Factor Xa Inhibitors -- pharmacology
- Female
- Janus Kinase 2 -- metabolism
- MAP Kinase Signaling System -- drug effects
- Phosphorylation -- drug effects
- Pyrazoles -- pharmacology
- Pyridones -- pharmacology
- Rats
- Rats, Wistar
- STAT3 Transcription Factor -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.